VantAI, a specialist in generative AI for proximity drug discovery, and Halda Therapeutics, a company focused on regulated ...

Swiss pharma company Idorsia announced that its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan), has ...

PTC Therapeutics yesterday revealed that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL ...

The Alzheimer’s disease (AD) market across the eight major markets (8MM: USA, France, Germany, Italy, Spain, UK, Japan, and ...

The US Food and Drug Administration (FDA) has extended Regenxbio’s review timeline of the Biologics License Application (BLA) ...

Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...

Germany’s Institute for Quality and Efficiency in Health Care concluded that Columvi (glofitamab) monotherapy shows no added ...

The US regulator has issued draft guidance urging drug developers to prioritize overall survival as the primary endpoint in ...

The European Commission (EC) has granted conditional marketing authorization for Madrigal Pharmaceuticals' Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic metabolic ...

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies (Nasdaq: ADPT) said Monday that its strategic ...

Shares of San Diego, USA-based Viking Therapeutics tumbled 43% to $23.50 by mid-morning after the company released mid-stage ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...